Stago
Created in 1945
Up & running (A)
Existing signals show a regular activitySocial networks
669 49,417 49,417Entity types
Location
3 All. Theresa, 92600 Asnières-sur-Seine, France
Asnières-sur-Seine
France
Employees
Scale: 1001-5000
Estimated: 2,017
Engaged catalyst
5
0 0Added in Motherbase
2 years, 1 month ago
Value proposition
Diagnostics is in our blood.
Created in 1945 as a pharmaceutical company, Diagnostica Stago is now a world leader in the In-Vitro Diagnostics industry. Global, privately-owned and independent, Stago is fully dedicated to the exploration of Thrombosis and Haemostasis.
Day in and day out, Stago is committed to enhancing the quality of healthcare by offering laboratories advanced testing systems and superior services, the fruit of our expertise and know-how in Haemostasis (reagents, instruments and disposables).
Distributed in over 110 countries through a network of subsidiaries and exclusive distributors, we are in a position to guarantee our customers superior service and a product portfolio meeting the demands of global healthcare systems. Today, 90% of our production, developed and made in France, is exported.
Specialising in the field of coagulation for over 60 years, Stago has acquired solid industrial experience (R&D, standardisation and production) in the field of In Vitro Diagnostics and lasting recognition from the scientific community.
The field of biomedical science is constantly evolving and expanding; new discoveries are moving medicine increasingly towards individual treatments that require diagnostic markers and ever more precise exploratory tools. These are our challenges of tomorrow.
Stago, relying on strong human and technological potential, will still have much to contribute in the years to come.
This LinkedIn page is dedicated to the Healthcare professionals.
Haemostasis, Coagulation, Routine reagents, Reagents for research, Coagulation devices, and ThrombosisOriginal language
Diagnostics is in our blood.
Créée en 1945 en tant que société pharmaceutique, Diagnostica Stago est aujourd'hui l'un des leaders mondiaux du secteur des diagnostics in vitro. International, privé et indépendant, Stago se consacre entièrement à l'exploration de la thrombose et de l'hémostase. Stago s'engage jour après jour à améliorer la qualité des soins aux patients en proposant aux laboratoires des systèmes d’analyses avancés et des services associés de haut niveau, fruit de notre expertise et de notre savoir-faire en hémostase (réactifs, instruments et consommables). Distribués dans plus de 110 pays à travers un réseau de filiales et de distributeurs exclusifs, nous sommes en mesure de garantir à nos clients un service de qualité supérieure et un portefeuille de produits répondant aux exigences des systèmes de santé mondiaux. Aujourd'hui, 90% de notre production, développée et fabriquée en France, est exportée. Spécialisé dans le domaine de la coagulation depuis plus de 60 ans, Stago a acquis une solide expérience industrielle (R & D, normalisation et production) dans le domaine du diagnostic in vitro et une reconnaissance durable de la communauté scientifique. Le domaine des sciences biomédicales évolue et se démocratise constamment ; les nouvelles découvertes orientent de plus en plus la médecine vers des traitements individuels nécessitant des marqueurs diagnostiques et des outils exploratoires de plus en plus précis. Ce sont nos défis de demain. Stago, s'appuyant sur un fort potentiel humain et technologique et aura encore beaucoup à apporter aux patients dans les années à venir.
Advanced Hemostasis and Thrombosis Analysis Solutions Provider | Stago
At Stago, we are dedicated to providing advanced solutions for hemostasis and thrombosis analysis. Our innovative analyzer and reagent systems are trusted by clinical and research laboratories worldwide. Contact us to learn more
https://www.stago.com/
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
 Noshaq Venture Capital and Private Equity Principals | Noshaq Venture Capital and Private Equity Principals | Other 16 Feb 2025 | | |
 Resah Health, Government Administration | Resah Health, Government Administration | Other 6 Aug 2024 | | |
 UGAP National and local authorities, Government Administration | UGAP National and local authorities, Government Administration | Other 8 Feb 2025 | | |
 Fondation Adolphe de Rothschild NGO, Think Tank, Hospitals and Health Care | Fondation Adolphe de Rothschild NGO, Think Tank, Hospitals and Health Care | Other 31 Oct 2024 | | |
 Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Other 10 Oct 2022 | | |